Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Clasificación en acciones #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Precio por acción
$7.15
Capitalización bursátil
$313.60M
Cambio (1 día)
-2.12%
Cambio (1 año)
-84.14%
País
DE
Comercio Anbio Biotechnology Class A Ordinary Shares (NNNN)

Categoría

Historial de rendimiento por dividendo de Anbio Biotechnology Class A Ordinary Shares (NNNN)
Rendimiento por dividendo (TTM) de Anbio Biotechnology Class A Ordinary Shares (símbolo bursátil: NNNN) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Anbio Biotechnology Class A Ordinary Shares (NNNN) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
0.00%
US
2.49%
FR
0.00%
JP
1.99%
US
0.00%
CH